new york 1997-03-31 while shares of columbia/hca healthcare corp took a beating monday following a federal probe and media reports about its billing practices , industry analysts continued to support the stock. anyone who is selling will probably regret it long-term , _ said brian eisenbarth , an analyst with collins & co. _ the market is pricing in a_lot_of bad news that , on the surface , dosen't seem that big of a deal , _ eisenbarth. the probe covered a _ broad range of records and documents _ and was completed by march 20 , the company said. _ if regulators believed that the problems were systemic , they would have gone into many locations. so , the fact that they are only in one location leads one to think that it_ 's not a company-wide issue , _ joseph chiarelli , an analyst with j.p. morgan securities. _ what would make me uncomfortable is if the government went into other markets and locations at columbia. investor concerns also have been fueled by a recent new york times report concerning the nashville , tenn.-based company's medicare coding practices and physician ownership in certain of its hospitals. analysts cautioned that the new york times used its own methodology , which has not been verified by others in the healthcare industry , as the basis of its article. ( ( new york newsdesk 212-859-1610 ) ) 